Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New data on the antitumor efficacy and toxicity of S-16020-2 in refractory tumors

Feb. 18, 2003

Introgen to pursue registration plans for Advexin in NSCLC

Feb. 18, 2003

Phase III atrasentan study fails to meet primary endpoint in end-stage prostate cancer

Feb. 18, 2003

Wilex and San Raffaele sign cleaved uPA receptor agreement

Feb. 18, 2003

Targeted chemotherapy of endometrial and ovarian cancers with cytotoxic LHRH analogue

Feb. 18, 2003

Antitumor antibiotic isolated by Nippon Kayaku scientists

Feb. 18, 2003

New protein kinase inhibitors covered by Aventis patent

Feb. 18, 2003

Phase I StemEx trial begins patient enrollment

Feb. 17, 2003

BioMS makes plans for phase I trial of HYC-750

Feb. 17, 2003

Telik and Vanderbilt-Ingram Cancer Center sign agreement for cancer drug discovery

Feb. 14, 2003

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...